[Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas].
Banzo
J
J
Servicio de Medicina Nuclear, Hospital Clínico Universitario Lozano Blesa, Zaragoza.
Abós
M D
MD
Prats
E
E
García
F
F
Razola
P
P
D000465:Algorithms; D000818:Animals; D001667:Binding, Competitive; D014408:Biomarkers, Tumor / Q000032:analysis*; D017321:Clinical Trials, Phase I as Topic; D005770:Gastrointestinal Neoplasms / Q000737:chemistry / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000628:therapy; D006801:Humans; D007205:Indium Radioisotopes / Q000493:pharmacokinetics / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009363:Neoplasm Proteins / Q000032:analysis*; D009367:Neoplasm Staging / Q000379:methods*; D018358:Neuroendocrine Tumors / Q000737:chemistry / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000628:therapy; D009479:Neuropeptides / Q000378:metabolism; D015282:Octreotide / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D010190:Pancreatic Neoplasms / Q000737:chemistry / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000628:therapy; D004369:Pentetic Acid / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D015642:Radiology, Interventional; D011877:Radionuclide Imaging / Q000379:methods; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics / Q000627:therapeutic use; D017481:Receptors, Somatostatin / Q000032:analysis*; D012680:Sensitivity and Specificity; D013004:Somatostatin / Q000737:chemistry / Q000502:physiology
D014408:Biomarkers, Tumor; D007205:Indium Radioisotopes; D009363:Neoplasm Proteins; D009479:Neuropeptides; D019275:Radiopharmaceuticals; D017481:Receptors, Somatostatin; C071632:SDZ 215-811; D013004:Somatostatin; D004369:Pentetic Acid; D015282:Octreotide